Common cold sore drug investigated to fight Alzheimer's
NCT ID NCT04710030
Summary
This study tested whether a high dose of the antiviral drug valacyclovir, commonly used for herpes, could slow down early memory loss linked to Alzheimer's disease. It involved 50 older adults who had mild memory problems, tested positive for herpes simplex virus, and showed early Alzheimer's biomarkers. Participants took either the drug or a placebo for one year to see if it reduced brain changes and cognitive decline.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New York State Psychiatric Institute
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.